Curcumin dosage

Protocol

1. 1

   Measure the dose

   Typical Curcumin dose is 500 mg (200 to 500 mg/day for high-bioavailability formulations (Meriva, BCM-95, Theracurmin); 500 to 1500 mg/day for standard curcuminoid extracts). Use a weight-based calculator for individual adjustments.

   Open tool →
2. 2

   Set the frequency

   Administer 1 to 2 times daily with meals. Half-life of 7 hours anchors the dosing interval.

   Open tool →
3. 3

   Cycle if needed

   No cycling required; studied continuously up to 18 months without safety signals at typical doses

   Open tool →
4. 4

   Monitor for side effects

   Watch for: nausea; diarrhea; dyspepsia; yellow stool (benign). Stop or reduce dose if tolerability breaks down.

Why this dose

Inhibits NF-kB transcription factor, COX-2, and lipoxygenase; activates AMPK and Nrf2; modulates JAK-STAT and PI3K-Akt kinase signaling. Pleiotropic anti-inflammatory and antioxidant effects.

The typical dose (500 mg) reflects 200 to 500 mg/day for high-bioavailability formulations (Meriva, BCM-95, Theracurmin); 500 to 1500 mg/day for standard curcuminoid extracts. Individual response varies with body weight, baseline status, concurrent training, and concurrent medications, so the labeled range is the starting point rather than the prescription.

How to administer

Curcumin is administered via the oral route. Oral dosing is straightforward: take with water, with or without food unless specifically noted.

Onset of action runs around 2 hours after administration. Peak effect lands near 4 hours post-dose. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.

Half-life note: Plasma half-life ~6 to 8 hours for enhanced formulations; standard curcumin has so little systemic exposure that meaningful half-life is hard to characterize

Cycling and tolerance

No cycling required; studied continuously up to 18 months without safety signals at typical doses

Effects to expect at typical dose

• Reduces osteoarthritis knee pain comparable to ibuprofen at 1500 mg/day enhanced formulation
• Modest antidepressant effect (SMD ~0.34) as monotherapy or SSRI adjunct in major depression
• Standard curcumin has ~3% bioavailability; Meriva, BCM-95, Theracurmin shift absorption 5-30 fold
• Inhibits NF-kB and COX-2; reduces hs-CRP, IL-6, TNF-alpha in chronic inflammation
• Antiplatelet effect at higher doses; meaningful interaction with warfarin and DOACs
• Iron chelation can contribute to deficiency in already-marginal patients

Side effects and interactions

Common side effects

• nausea
• diarrhea
• dyspepsia
• yellow stool (benign)

Notable interactions

• warfarin and DOACs (major): additive antiplatelet and anticoagulant effects; meaningful bleeding risk at 1000+ mg/day
• chemotherapy agents (major): potential interference with multiple agents; coordinate with oncology team
• aspirin and NSAIDs (moderate): additive antiplatelet effect
• tacrolimus and cyclosporine (moderate): CYP3A4 and P-gp modulation may alter drug levels
• iron supplements (moderate): curcumin chelates iron; can contribute to deficiency in marginal patients

Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full Curcumin profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.

Regulatory snapshot

WADA status

allowed

DEA / Rx

Not scheduled

Pregnancy

Culinary turmeric is safe; supplemental curcumin best avoided in pregnancy

Legal status

Dietary supplement (global)

Do not use if

• active gallstones (curcumin stimulates gallbladder contraction)
• severe biliary obstruction
• scheduled elective surgery (discontinue 1-2 weeks prior)

Related research